September 29, 2025

Glaukos Corporation (GKOS) Stock Analysis: Navigating the 52.65% Potential Upside in the Healthcare Sector

Glaukos Corporation (GKOS), a key player in the healthcare sector, stands out in the niche field of ophthalmic pharmaceuticals and medical technology. With a focus on developing innovative therapies for..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a Compelling 78% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, stands out as a compelling investment opportunity with a strong potential upside. With a market capitalization of $10.34..

Chemed Corp (CHE) Stock Analysis: Unpacking the 25% Potential Upside in Healthcare

For investors seeking an intriguing opportunity in the healthcare sector, Chemed Corp (NYSE: CHE) presents a compelling case. With a market capitalization of $6.74 billion, Chemed operates primarily in the..

Legend Biotech (LEGN) Stock Analysis: Unlocking a 129.77% Potential Upside in the Biotech Arena

Legend Biotech Corporation (NASDAQ: LEGN), a trailblazer in the biopharmaceutical realm, is capturing investor attention with a significant 129.77% potential upside. As a leader in developing innovative cell therapies, Legend..

Centene Corporation (CNC) Stock Analysis: Understanding the Healthcare Giant’s Current Valuation and Investor Sentiment

Centene Corporation (NYSE: CNC), a formidable player in the healthcare plans industry, is currently in the spotlight for investors seeking to navigate the complexities of the healthcare sector. With a..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unveiling a Potential 212.93% Upside

For investors with an eye for opportunities in the biotechnology sector, Vaxcyte, Inc. (NASDAQ: PCVX) presents an intriguing prospect. Despite the company’s current share price of $33.98, analysts have set..

Viatris Inc. (VTRS) Stock Analysis: Exploring a Potential 20% Upside Amid High Dividend Yield

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, has caught the attention of investors with its enticing potential upside of 20.05%, according to analysts’ projections. Trading at..

Alkermes plc (ALKS) Stock Analysis: Exploring a 49.54% Potential Upside in the Healthcare Sector

Alkermes plc (NASDAQ: ALKS), an Irish biopharmaceutical company, stands out in the healthcare sector with a promising potential upside of 49.54%, capturing the attention of investors looking for growth opportunities..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 31.96% Potential Upside Amid Strong Buy Ratings

Intuitive Surgical, Inc. (NASDAQ: ISRG), a prominent leader in the healthcare sector’s Medical Instruments & Supplies industry, is drawing significant attention from investors. With a robust market capitalization of $158.13..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a Remarkable 71.84% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is a biotechnology firm that is attracting significant attention within the healthcare sector. Headquartered in Redwood City, California, this clinical-stage precision oncology company is pioneering..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Leader with Strong Buy Ratings and Strategic Collaborations

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a trailblazer in the biotechnology sector, has been making waves with its innovative therapeutic solutions based on ribonucleic acid interference (RNAi). With a market capitalization..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring Growth Potential Amid 1,353.80% Revenue Surge

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a key player in the biotechnology sector, is attracting significant attention from investors, thanks to its remarkable revenue growth of 1,353.80%. This Pennsylvania-based company is..

Abbott Laboratories (ABT) Stock Analysis: Unlocking a 6.87% Potential Upside with Robust Growth and Dividend Stability

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector and a leading player in the medical devices industry, commands a significant presence with a market capitalization of $232.44 billion...

Natera, Inc. (NTRA) Stock Analysis: Evaluating the 18.92% Upside Potential in Healthcare Diagnostics

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare diagnostics sector, offers a suite of advanced molecular testing services that are gaining significant traction worldwide. With a market capitalization..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Unveiling the Potential in Traditional Chinese Medicine

Regencell Bioscience Holdings L (RGC) stands as a compelling entity within the healthcare sector, specifically nestled in the niche of drug manufacturing, both specialty and generic. With its focus on..

GSK plc (GSK) Investor Outlook: Navigating a 3.89% Potential Upside with Strong Dividend Yield

In the dynamic realm of healthcare, GSK plc (NYSE: GSK) stands as a formidable titan, commanding a market capitalization of $80.2 billion. As a stalwart in the Drug Manufacturers –..

Elanco Animal Health (ELAN) Stock Analysis: Is the Veterinary Leader’s Growth Sustainable?

Elanco Animal Health Incorporated (NYSE: ELAN), a stalwart in the healthcare sector, is a pivotal player in the Drug Manufacturers – Specialty & Generic industry. With a market capitalization of..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 14% Potential Upside Amidst Healthcare Innovation

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector, continues to garner attention from investors with its robust portfolio in the medical devices industry. Headquartered in Hercules, California,..

Nuvalent, Inc. (NUVL) Stock Analysis: Unlocking a 43% Potential Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL) has emerged as a notable player within the biotechnology industry, operating at the cutting edge of cancer treatment development. With a market capitalization of $5.87 billion,..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: A 51% Upside Potential with Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM) stands out as a compelling investment opportunity within the biotechnology sector, particularly for those interested in the healthcare landscape. With its focus on central nervous..

Search

Funds

September 29, 2025

Search

Funds

September 29, 2025

FTSE 100

Funds